BACKGROUND: The Insomnia Severity Index (ISI) is an instrument to evaluate insomnia symptoms. The psychometric properties have not been established in adults (18 years of age or older) with sickle cell disease (SCD). OBJECTIVE: Evaluate the reliability and validity of the ISI among adults with SCD. METHODS: Analysis included psychometric evaluation with exploratory factor analysis. RESULTS: Our 263 participants had a mean age of 35.6 years and primarily were female (54.8%) with HbSS genotype (69.2%). Almost 41% were classified as clinical insomnia cases (ISI ≥14) using the traditional scoring approach. Two factors, Insomnia Symptoms and Insomnia Impact, emerged during factor analysis. Reliability of both factor-scales was good and each correlated with pain severity and depressive symptomatology (r = 0.38 to 0.66, p<.01). CONCLUSION: The ISI demonstrated construct validity and reliability for evaluating insomnia symptomatology among adults with SCD and can be used in research and clinical practice.
BACKGROUND: The Insomnia Severity Index (ISI) is an instrument to evaluate insomnia symptoms. The psychometric properties have not been established in adults (18 years of age or older) with sickle cell disease (SCD). OBJECTIVE: Evaluate the reliability and validity of the ISI among adults with SCD. METHODS: Analysis included psychometric evaluation with exploratory factor analysis. RESULTS: Our 263 participants had a mean age of 35.6 years and primarily were female (54.8%) with HbSS genotype (69.2%). Almost 41% were classified as clinical insomnia cases (ISI ≥14) using the traditional scoring approach. Two factors, Insomnia Symptoms and Insomnia Impact, emerged during factor analysis. Reliability of both factor-scales was good and each correlated with pain severity and depressive symptomatology (r = 0.38 to 0.66, p<.01). CONCLUSION: The ISI demonstrated construct validity and reliability for evaluating insomnia symptomatology among adults with SCD and can be used in research and clinical practice.
Authors: Khosro Sadeghniiat-Haghighi; Ali Montazeri; Ahmad Khajeh-Mehrizi; Saharnaz Nedjat; Omid Aminian Journal: Qual Life Res Date: 2013-08-03 Impact factor: 4.147
Authors: Louise H Anderson; Robin R Whitebird; Jennifer Schultz; Charlene E McEvoy; Mary Jo Kreitzer; Cynthia R Gross Journal: Am J Manag Care Date: 2014-05 Impact factor: 2.229
Authors: Julie L Otte; Giorgos Bakoyannis; Kevin L Rand; Kristine E Ensrud; Katherine A Guthrie; Hadine Joffe; Susan M McCurry; Kathrine M Newton; Janet S Carpenter Journal: Menopause Date: 2019-08 Impact factor: 3.310